1960) and a central effect (Gillespie et alc., 1962) may play some part. Agar et al. (1958) discussed the underlying theories of pre-eclamptic hypertension production in view of mecamylamine and the ganglion-blocking hypotensive agents being ineffectual in controlling this condition. Recently, Senior et al. (1963) have suggested that 5-hydroxytryptamine (serotonin) may have some role in the production of toxaemia of pregnancy and that antagonists of this substance may be of value in treatment. It is of interest that methyldopa interferes with the formation of serotonin in the body (Oates et al., 1960) .
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Summary
Methyldopa and the chlorothiazide diuretics have been used in 15 patients with severe pre-eclamptic toxaemia. All but one showed a marked and satisfactory fall in blood-pressure, a diminution in proteinuria, and improvement in well-being.
The foetus died early in treatment in three patients. All three had severe toxaemia occurring early in the third trimester and showed blood ureas above normal-one of them had the unsuccessful blood-pressure response. The other patients were able to continue with the pregnancies and all were delivered of healthy normal babies except one baby who died of an obstetric cause.
The dose of methyldopa was relatively small and the only complication was a drug rash, but other drugs were being given at the same time. However, the number of patients was small and other side-effects may occur. No deterioration has been noted in following the condition of these patients.
We should like to thank Mr. Alan Brews for permission to publish his cases.
Pre-eclampsia remains a common complication of pregnancy in this country. Although the foetal wastage appears to be slightly less now than ten years ago, the figures from the National Birthday Trust Perinatal Mortality Survey show that in pregnancies resulting in stillbirth or neonatal death there is still a raised incidence of pre-eclampsia (D. G. Bonham, personal communication, 1963) . It is also one of the three most common features of the history where the mother has died ; 18% of maternal deaths are associated with pre-eclampsia (Ministry of Health, 1963) .
In spite of the importance of the condition the cause remains obscure, and treatment, although relatively successful, is still largely empirical. Hypotensive drugs may have value if given early in pregnancy, but this treatment is possible only for those women who show early hypertension. In cases of non-toxaemic hypertension reserpine seems to have a place but does not reduce foetal loss (Landesman and Ollstein, 1958) . In true preeclampsia hypotensive drugs can only be given late and the results are disappointing. A large number of clinicians still rely on prescribing a sedative and advising bed rest, and of these two methods rest in bed is the least empirical. It is known that the myometrial blood-flow is decreased in preeclampsia (Morris et al., 1955 ; Dixon et al., 1963) , but with rest this is greatly improved (Morris et al., 1956 ). Rest also results in an increased urinary volume and sodium excretion (Thomas, 1957 (Thomas, , 1959 . Unfortunately, such a line of treatment necessitates the early admission of large numbers of women to hospital. In most units such a policy leads to overcrowding in the antenatal wards. From the patient's point of view the prolonged separation from husband and family is an intolerable strain. Many of these women prefer to decline admission and accept the risk of remaining an out-patient.
At University College Hospital, London, the demand for antenatal beds is never satisfied. In 1950 1,270 patients were delivered and the foetal mortality associated with pre-eclampsia (excluding essential hypertension) was 4.5%. This figure was achieved by admitting, for periods ranging as high as 38 days, 48 of 66 mothers suffering from the complication. Furthermore, of the 57 surgical inductions in that year, 37 were for hypertension in pregnancy (Musgrove, 1950) . Greater attention is now paid to minor signs of pre-eclampsia; this has resulted in a greater number of diagnoses over latter years. In spite of these new diagnostic criteria there has been little improvement in the perinatal mortality. During 1960 out of a total of 1,358 delivered patients 223 (16.4%) were diagnosed as having pre-eclampsia. The perinatal mortality was 3.14 %. To produce this reduction of less than 1.4 % all but 48 were admitted to hospital-that is, 175 women spent up to a maximum of 90 days in hospital (Woolf, 1960 A line of therapy which enabled the obstetrician to delay admission would therefore be of benefit, and it appeared that the thiazide group of diuretics might be well suited for this purpose.
The main properties of the drugs are that they cause a diuresis, increase sodium excretion, and antagonize noradrenaline (Wilson, 1963) . There is also a hypotensive action which cannot be solely explained by relating it to increased salt excretion (Pickering et al., 1961 ; Villarreal et al., 1962) . A possible disadvantage is that there may be an excessive potassium loss. A hyperglycaemic action is known which may reveal latent diabetes mellitus (Goldner et al., 1960) . Such an action increases the difficulties of management in established diabetes, but the effect appears to be reversible (Shapiro et al., 1961) . O5ther complications are rare and there are few toxic reactions.
Skin rashes, thrombocytopenic purpura, and pancreatitis are reported (Laragh, 1962) , but so far no teratogenic effect has been seen.
Thiazides have been used in pre-eclampsia by several investigators. Finnerty et al. (1958) recorded a fall in blood-pressure of more than 20%. Tatum and Waterman (1961) reported a reduced incidence of pre-eclampsia from 4% to 2% in 144 patients, but it is doubtful whether there is a concomitant reduction in the perinatal mortality (Soiva and Gronroos, 1963) . Lennon (1959) If one or more of these criteria were found the treatment was started. No case of albuminuria without one or two of the above signs was encountered.
Schemes of Medication
Chlorothiazide Group.-These women were given 0.5 g. of chlorothiazide twice daily together with varnished potassium chloride tablets 1 g. twice daily. No rest, special diet, or sedation was recommended.
Phenobarbitone Group.-A low-salt 1,800-calorie diet was given to these patients. Full dietetic instruction was arranged and advice given on rest at home. Phenobarbitone 25 mg. was prescribed orally three times daily.
After a week of treatment the patient was reconsidered. If the signs of toxaemia had disappeared so that she no longer fell within the stated limits, then chlorothiazide was stopped, but women having phenobarbitone continued to receive it. Where there had been no deterioration in the condition but where the indications for treatment-namely, blood-pressure, oedema, or weight gain-still persisted, then chlorothiazide was given for a further week. This is distinct from the usual practice of prescribing the thiazides for short periods only. The choice was deliberate and represented an attempt to compare the hypotensive action of chlorothiazide with the diuretic action. On occasion, discontinuance of the chlorothiazide was followed by relapse, so that there was once more an indication for treatment, which was repeated. No patient was transferred from one group to the other, and the figures given below represent the number of patients treated, not the number of treatments given.
In a number of cases the condition worsened. Admission was advised if the blood-pressure rose to figures in excess of 145 mm. Hg systolic or 85 mm. Hg diastolic. Irrespective of blood-pressure, the patient was also admitted if she gained more than 2 lb. (907 g.) in weight during one week under treatment or if her oedema increased substantially. The appearance of non-infective albuminuria was regarded as an absolute indication for admission. Admission to hospital on account of preeclampsia was the end point of the trial. Subsequent progress and the final result of the pregnancy were recorded, but once she had been admitted the patient's treatment was conducted quite independently of the trial.
Analysis of Cases
In all, 105 mothers were selected for the trial. As has previously been mentioned, five of these cases were later rejected when it became clear that they had not taken the drugs prescribed for them. Of the remaining 100 women 46 were in the phenobarbitone and 54 in the chlorothiazide group.
It was hoped that the random selection would result in two similar groups, and examination of the records confirmed this.
The age distribution was a close parallel (Table I ). Rejected cases are given in parentheses.
As regards parity, 38 women out of the 100 had had previous pregnancies, 20 of these patients being in the phenobarbitone and 18 in the chlorothiazide group. As the latter is the larger it will be seen that there is a greater proportion of primigravidae in this group (67%) as compared with the phenobarbitone/diet group (51 %), but the difference is not significant. Within the phenobarbitone group there were two sets of twins, but neither mother was admitted to hospital on account of pre-eclampsia and neither developed hypertension. The indications for treatment differed little between the two groups. Rather more women appeared to be admitted to the chlorothiazide group with excess weight gain or oedema (Table II) , but a similar number in each group had oedema without hypertension. barbitone group there were one neonatal death and one stillbirth, and in the group having chlorothiazide one stillbirth and two neonatal deaths-one from haemorrhage associated with thrombocytopenic purpura and the other from prematurity. The mother of the child with thrombocytopenia had a total of 24 g. of chlorothiazide over a six-weeks period. Examination of her blood showed no maternal thrombocytopenia. It should be remembered that this condition appears sporadically, without a known cause, in otherwise normal pregnancies (Willis, 1962,. In fact, this patient has recently delivered herself of another affected child, no chlorothiazide having been given in the second pregnancy. The perinatal death rate for the trial is nearly 5%. In 223 cases of pre-eclampsia seen in 1960 the perinatal mortality was 3.15% (Table V) . This difference is not significant, but it is fair to conclude that there is no evidence of a reduced foetal wastage resulting from the treatment in the trial groups. The length of treatment in the two groups cannot be compared, because the administration of phenobarbitone was continuous while that of chlorothiazide was intermittent. Five women were given less than 7 g. of chlorothiazide. Seven had 7 to 14 g. and 42 had more than 14 g.
Glycosuria
One patient in the phenobarbitone group was found to be diabetic. Three patients having chlorothiazide developed glycosuria, but in each the fasting blood-sugar level was normal, as were their glucose-tolerance tests. Two of these women, and the diabetic patient, had children weighing over 8 lb. (3,630 g.) at birth.
Results
Where phenobarbitone and diet had been prescribed, 22 out of 46 patients were admitted on account of pre-eclampsia. Of the larger chlorothiazide group only 11 women required admission (Table III).   TABLE III Significantly fewer women required admission if they were receiving chlorothiazide. Both groups compare favourably with the overall admission rate for the previous year (Woolf, 1960) (Table IV) .
Births in toxaemic patients (1960) . . x2=0 2; P<07.
Anaemia.-To ensure that no depression of erythropoiesis was occurring routine haemoglobin estimation was carried out. For the purpose of comparison the haemoglobin on the fourth day of the puerperium is the figure quoted. Nine women in the barbiturate group had a haemoglobin of less than 10.5 g., compared with 10 in the diuretic group. Seven estimates were omitted-two in the phenobarbitone group and five in the chlorothiazide group. Electrolytic imbalance was a possibility but none was demonstrated. Potassium shift from the myometrial cells has been described in prolonged labour (Hawkins and Nixon, 1958) and may affect uterine action. For this reason the length of labours was considered (Table VI) . The difference is not significant, and no interference with labour need be anticipated as a result of chlorothiazide administration. Mortality.-No eclampsia occurred within the two groups.
No mothers died, but five children were lost. In the pheno- Blood-pressure Under Treatment.-There is in fact no significant difference between the two groups, but chlorothiazide is as good as phenobarbitone, rest, and diet in controlling bloodpressure (Table VIII) .
Discussion
The benefit from chlorothiazide therapy in pregnancy may be due to the increased steroid production of pregnancy. Aldosterone is known to be present in the placenta in large quantities and bound cortisol levels in maternal plasma are raised. In the presence of aldosterone the thiazides cause an increased sodium/potassium exchange and a disproportionate sodium excretion ; cortisone merely increases the exchange. Excessive loss of fluid may predispose patients to thrombophlebitis, but in this series there was only one case of venous thrombosis.
At first the dosage was thought to be somewhat high, but the satisfactory response and the absence of severe toxic effects suggest that a high dose is both desirable and safe. There were three minor skin eruptions and a case of pruritus vulvae. apparently due to chlorothiazide. Two of the patients having phenobarbitone developed puerperal sepsis; two having chlorothiazide exhibited symptoms of psychosis after delivery. In none of the four cases was the complication thought to be attributable to medication. Although no hyperglycaemia was seen in this series subsequent use has confirmed other workers' experience with chlorothiazide in diabetes. More recently administration of chlorothiazide to a diabetic mother for 24 hours has resulted in a threefold increase in blood sugar at 30 weeks of pregnancy. Diabetes mellitus is now considered to be a contraindication to treatment with thiazide derivatives. All other pregnant women who have hypertension, oedema, or excessive gain in weight appear to be suitable for early and prolonged treatment with this drug.
Summary
A group of 100 women were given random treatment with either, phenobarbitone and diet restriction or chlorothiazide alone. From the point of view of enabling patients with mild pre-eclampsia to be treated as out-patients the chlorothiazide group is significantly better. Despite delayed admission the maternal results were good. The perinatal mortality was similar -4.4%,b in the phenobarbitone group and 5.5% in the chlorothiazide group. The trial as a whole did not improve the perinatal mortality in the unit, but there was no significant increased foetal loss.
